治疗方案-话题@MedSci

#治疗方案#

313篇内容 | 3226人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1905079, encodeId=5ec819050e996, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=2018共识建议：轻中度溃疡性结肠炎以患者为中心的治疗方案, objectType=article, longId=151915, objectId=1e8415191583, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e8415191583, replyNumber=0, likeNumber=26, createdTime=2019-05-08, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e8415191583, moduleTitle=2018共识建议：轻中度溃疡性结肠炎以患者为中心的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e8415191583)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905070, encodeId=3fae19050e04f, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet Gastroen Hepatol：轻中度溃疡性结肠炎药物治疗方案效果评估, objectType=article, longId=147068, objectId=990314e06864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=990314e06864, replyNumber=0, likeNumber=150, createdTime=2019-07-10, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=990314e06864, moduleTitle=Lancet Gastroen Hepatol：轻中度溃疡性结肠炎药物治疗方案效果评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=990314e06864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905083, encodeId=efff190508358, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Semin Arthritis Rheu：免疫检查点抑制剂诱导的炎性关节炎临床表现因免疫治疗方案而异, objectType=article, longId=156411, objectId=26a0156411e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26a0156411e1, replyNumber=0, likeNumber=62, createdTime=2019-02-26, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26a0156411e1, moduleTitle=Semin Arthritis Rheu：免疫检查点抑制剂诱导的炎性关节炎临床表现因免疫治疗方案而异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=26a0156411e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905068, encodeId=166b1905068de, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=世卫组织推荐多替拉韦为一线**艾滋病治疗方案, objectType=article, longId=146275, objectId=ec191462e5e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec191462e5e2, replyNumber=0, likeNumber=74, createdTime=2019-03-02, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec191462e5e2, moduleTitle=世卫组织推荐多替拉韦为一线**艾滋病治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec191462e5e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905091, encodeId=e50919050911a, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=老年食管炎伴吞咽困难，治疗方案如何选择？, objectType=article, longId=166698, objectId=989d16669857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=989d16669857, replyNumber=0, likeNumber=65, createdTime=2020-04-27, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=989d16669857, moduleTitle=老年食管炎伴吞咽困难，治疗方案如何选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=989d16669857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905096, encodeId=27ea1905096bb, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=晚期胃癌中国研究，为胃癌治疗提供新治疗方案, objectType=article, longId=168242, objectId=c3001682422e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3001682422e, replyNumber=0, likeNumber=103, createdTime=2020-01-28, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3001682422e, moduleTitle=晚期胃癌中国研究，为胃癌治疗提供新治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3001682422e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905098, encodeId=57601905098f7, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Radiology：霍奇金淋巴瘤和侵入性非霍奇金淋巴瘤分期和治疗方案制定借助CT好还是PET/CT好？, objectType=article, longId=168310, objectId=3174168310ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3174168310ef, replyNumber=0, likeNumber=79, createdTime=2020-01-02, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3174168310ef, moduleTitle=Radiology：霍奇金淋巴瘤和侵入性非霍奇金淋巴瘤分期和治疗方案制定借助CT好还是PET/CT好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3174168310ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905099, encodeId=6b461905099af, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=EGFR突变阳性晚期NSCLC的治疗方案选择, objectType=article, longId=168402, objectId=fee316840246, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fee316840246, replyNumber=0, likeNumber=54, createdTime=2019-11-10, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fee316840246, moduleTitle=EGFR突变阳性晚期NSCLC的治疗方案选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fee316840246)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905069, encodeId=b0a51905069b7, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=中国PCSK9抑制剂瑞百安获批安进为HoFH患者提供创新治疗方案, objectType=article, longId=146337, objectId=ea6914633ee6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea6914633ee6, replyNumber=0, likeNumber=55, createdTime=2018-10-08, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea6914633ee6, moduleTitle=中国PCSK9抑制剂瑞百安获批安进为HoFH患者提供创新治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea6914633ee6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905090, encodeId=50cd190509015, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=扩心病心衰难以控制？这个治疗方案事半功倍！, objectType=article, longId=163029, objectId=052f163029d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=052f163029d8, replyNumber=0, likeNumber=65, createdTime=2019-04-17, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=052f163029d8, moduleTitle=扩心病心衰难以控制？这个治疗方案事半功倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=052f163029d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905078, encodeId=0eee19050e862, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=FDA延长了对Opdivo/Yervoy联合治疗方案的审查, objectType=article, longId=151495, objectId=41d015149554, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41d015149554, replyNumber=0, likeNumber=59, createdTime=2019-05-11, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41d015149554, moduleTitle=FDA延长了对Opdivo/Yervoy联合治疗方案的审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41d015149554)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905086, encodeId=ce9f19050865a, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=骨质疏松患者摔伤右腕肿胀畸形哪种治疗方案效果佳？, objectType=article, longId=160412, objectId=0ad816041221, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ad816041221, replyNumber=0, likeNumber=68, createdTime=2019-09-14, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ad816041221, moduleTitle=骨质疏松患者摔伤右腕肿胀畸形哪种治疗方案效果佳？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ad816041221)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905084, encodeId=71c31905084d3, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Graves眼病4种治疗方案汇总，快收藏！, objectType=article, longId=158488, objectId=7fdf1584880e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fdf1584880e, replyNumber=0, likeNumber=72, createdTime=2019-06-22, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fdf1584880e, moduleTitle=Graves眼病4种治疗方案汇总，快收藏！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fdf1584880e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905059, encodeId=ccbf1905059ca, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=J Viral Hepat：在荷兰，近期开始采用的DAA治疗方案，对HCV基因1b型患者，治疗较好；但对HCV基因3型患者，疗效较差, objectType=article, longId=140112, objectId=29041401126d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29041401126d, replyNumber=0, likeNumber=68, createdTime=2018-07-08, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29041401126d, moduleTitle=J Viral Hepat：在荷兰，近期开始采用的DAA治疗方案，对HCV基因1b型患者，治疗较好；但对HCV基因3型患者，疗效较差, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29041401126d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905080, encodeId=b7ee190508031, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet：度鲁特韦联合拉米夫定可作为HIV感染者的首先治疗方案, objectType=article, longId=153251, objectId=cb4915325177, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb4915325177, replyNumber=0, likeNumber=61, createdTime=2019-03-20, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb4915325177, moduleTitle=Lancet：度鲁特韦联合拉米夫定可作为HIV感染者的首先治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb4915325177)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905067, encodeId=a9d5190506e05, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Blood：复发性或难治性结节性淋巴细胞为主型霍奇金淋巴瘤的更佳治疗方案, objectType=article, longId=145707, objectId=7eea145e07b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7eea145e07b9, replyNumber=0, likeNumber=59, createdTime=2019-06-07, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7eea145e07b9, moduleTitle=Blood：复发性或难治性结节性淋巴细胞为主型霍奇金淋巴瘤的更佳治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7eea145e07b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905050, encodeId=9d7d1905050ef, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JACC：个性化抗血小板治疗方案对冠心病患者疗效更佳, objectType=article, longId=136845, objectId=69a9136845fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69a9136845fd, replyNumber=0, likeNumber=56, createdTime=2018-11-16, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69a9136845fd, moduleTitle=JACC：个性化抗血小板治疗方案对冠心病患者疗效更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69a9136845fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905074, encodeId=49e519050e462, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Blood：研究人员发现可鉴别多发性骨髓瘤患者对哪种治疗方案更敏感的基因印迹, objectType=article, longId=148311, objectId=72c21483118d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72c21483118d, replyNumber=0, likeNumber=79, createdTime=2019-06-04, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72c21483118d, moduleTitle=Blood：研究人员发现可鉴别多发性骨髓瘤患者对哪种治疗方案更敏感的基因印迹, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72c21483118d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905072, encodeId=da8919050e2fe, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=美国为Dravet综合征提供了新的治疗方案, objectType=article, longId=147459, objectId=7b3c14e4595b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b3c14e4595b, replyNumber=0, likeNumber=87, createdTime=2019-08-01, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b3c14e4595b, moduleTitle=美国为Dravet综合征提供了新的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b3c14e4595b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905060, encodeId=f65c1905060df, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Neurology：复发缓解多发性硬化症患者治疗方案选择——芬戈莫德 vs富马酸二甲酯, objectType=article, longId=140255, objectId=9662140255bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9662140255bb, replyNumber=0, likeNumber=91, createdTime=2018-12-07, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9662140255bb, moduleTitle=Neurology：复发缓解多发性硬化症患者治疗方案选择——芬戈莫德 vs富马酸二甲酯, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9662140255bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗方案

2020-05-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

2018共识建议：轻中度溃疡性结肠炎以患者为中心的治疗方案

2019-05-08

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet Gastroen Hepatol：轻中度溃疡性结肠炎药物治疗方案效果评估

2019-07-10

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Semin Arthritis Rheu：免疫检查点抑制剂诱导的炎性关节炎临床表现因免疫治疗方案而异

2019-02-26

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

世卫组织推荐多替拉韦为一线**艾滋病治疗方案

2019-03-02

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

老年食管炎伴吞咽困难，治疗方案如何选择？

2020-04-27

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

晚期胃癌中国研究，为胃癌治疗提供新治疗方案

2020-01-28

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Radiology：霍奇金淋巴瘤和侵入性非霍奇金淋巴瘤分期和治疗方案制定借助CT好还是PET/CT好？

2020-01-02

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

EGFR突变阳性晚期NSCLC的治疗方案选择

2019-11-10

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

中国PCSK9抑制剂瑞百安获批安进为HoFH患者提供创新治疗方案

2018-10-08

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

扩心病心衰难以控制？这个治疗方案事半功倍！

2019-04-17

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

FDA延长了对Opdivo/Yervoy联合治疗方案的审查

2019-05-11

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

骨质疏松患者摔伤右腕肿胀畸形哪种治疗方案效果佳？

2019-09-14

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Graves眼病4种治疗方案汇总，快收藏！

2019-06-22

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

J Viral Hepat：在荷兰，近期开始采用的DAA治疗方案，对HCV基因1b型患者，治疗较好；但对HCV基因3型患者，疗效较差

2018-07-08

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet：度鲁特韦联合拉米夫定可作为HIV感染者的首先治疗方案

2019-03-20

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Blood：复发性或难治性结节性淋巴细胞为主型霍奇金淋巴瘤的更佳治疗方案

2019-06-07

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JACC：个性化抗血小板治疗方案对冠心病患者疗效更佳

2018-11-16

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Blood：研究人员发现可鉴别多发性骨髓瘤患者对哪种治疗方案更敏感的基因印迹

2019-06-04

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

美国为Dravet综合征提供了新的治疗方案

2019-08-01

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Neurology：复发缓解多发性硬化症患者治疗方案选择——芬戈莫德 vs富马酸二甲酯

2018-12-07

科室
- - 订阅+
  - 更多科室
工具
服务